Patients News | pharmaphorum

News

The Trump administration's linking of autism to Tylenol and vaccines with no evidence raises concern about an FDA review of mifepristone's safety.

News

Bristol Myers Squibb expands its DTC sales in the US with the addition of psoriasis drug Sotyktu at an 80% discount for cash buyers.

News

After all the threats, it seems President Trump's tariffs on pharmaceuticals are coming to fruition, and a lot sooner than expected.

News

Biotechs Acadia Pharma and Harmony Biosciences both suffered setbacks in phase 3 trials of drugs for rare diseases, in one case ending the programme.

News

Medical groups have reacted with dismay after Trump linked childhood vaccinations and use of acetaminophen to autism.

News

After a long haul, Stealth BioTherapeutics has finally claimed FDA approval for Forzinity, the first treatment for ultra-rare disease Barth syndrome.